140 related articles for article (PubMed ID: 2162408)
1. [Clinical significance of DU-PAN-2 analysis as a tumor marker].
Sawabu N; Satomura Y
Nihon Rinsho; 1990 Feb; 48 Suppl():1003-7. PubMed ID: 2162408
[No Abstract] [Full Text] [Related]
2. [Clinical significance of pancreatic oncofetal antigen, pancreatic cancer associated antigen assay as tumor markers].
Shimano T; Morimoto H; Saito M; Mori T
Nihon Rinsho; 1990 Feb; 48 Suppl():917-9. PubMed ID: 2192174
[No Abstract] [Full Text] [Related]
3. [Clinical significance of YH-206 assay analysis as a tumor marker].
Yachi A; Hinoda Y; Imai K; Endo T
Nihon Rinsho; 1990 Feb; 48 Suppl():1068-70. PubMed ID: 2192107
[No Abstract] [Full Text] [Related]
4. [Clinical significance of TAC-41 assay as a tumor marker].
Ariyoshi Y; Kuwabara M; Iwakoshi N; Kito K
Nihon Rinsho; 1990 Feb; 48 Suppl():1060-3. PubMed ID: 2162412
[No Abstract] [Full Text] [Related]
5. [Tumor markers in hepatoma, gallbladder-biliary tract and pancreas cancer].
Nakahara M; Fujisawa K
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3010-9. PubMed ID: 2445292
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of NCC-ST-439 antigen assay detected by the monoclonal antibody as a tumor marker].
Sugano K; Okura H
Nihon Rinsho; 1990 Feb; 48 Suppl():1031-4. PubMed ID: 2192105
[No Abstract] [Full Text] [Related]
7. [Clinical significance of CA 195 assay as a tumor marker].
Ohkura H; Sakawaki T
Nihon Rinsho; 1990 Feb; 48 Suppl():982-4. PubMed ID: 2355639
[No Abstract] [Full Text] [Related]
8. [Tumor markers for hepatoma and carcinoma of biliary tract].
Higashino K
Rinsho Byori; 1985 Aug; 33(8):861-71. PubMed ID: 2416966
[No Abstract] [Full Text] [Related]
9. [DU-PAN-2 antigen in the serum of patients with tumors of the pancreas or biliary tract].
Ohshio G; Hamashima Y; Manabe T; Miyashita T; Suzuki T; Tobe T
Nihon Geka Gakkai Zasshi; 1987 Mar; 88(3):359. PubMed ID: 3600587
[No Abstract] [Full Text] [Related]
10. [Early diagnostic system of minute hepatocellular carcinoma, and neoplasms of biliary tract and pancreas].
Okuda K; Tsuchiya Y; Saisho H
Nihon Rinsho; 1982; 40(1):146-50. PubMed ID: 6283199
[No Abstract] [Full Text] [Related]
11. [Evaluation of KMO1 for the gastrointestinal disease].
Okumura S; Ohyanagi H; Saitoh Y
Nihon Rinsho; 1990 Feb; 48 Suppl():1017-21. PubMed ID: 2192103
[No Abstract] [Full Text] [Related]
12. Clinical application of a new monoclonal antibody (19B7) against PIVKA-II in the diagnosis of hepatocellular carcinoma and pancreatobiliary malignancies.
Nakao A; Taniguchi K; Inoue S; Takeda S; Harada A; Nonami T; Watanabe K; Takagi H
Am J Gastroenterol; 1997 Jun; 92(6):1031-4. PubMed ID: 9177525
[TBL] [Abstract][Full Text] [Related]
13. [Urine diacetylspermine as a novel tumor marker].
Yamaguchi K; Kaku T; Enjoji M; Kato M; Anai M; Kawakita M; Hamasaki N; Tanaka M
Rinsho Byori; 2005 Feb; 53(2):130-5. PubMed ID: 15796046
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of serum DU-PAN-2 surveyed by solid-phase sandwich EIA for DU-PAN-2].
Ishii M; Urabe T; Seino Y
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1860-5. PubMed ID: 3296960
[TBL] [Abstract][Full Text] [Related]
15. The carbohydrate antigenic determinant 19-9 (CA 19-9): a monoclonal antibody defined tumor marker.
DelVillano BC; Zurawski VR
Lab Res Methods Biol Med; 1983; 8():269-82. PubMed ID: 6196588
[No Abstract] [Full Text] [Related]
16. [Clinical significance of ST 272 Ag detected by the monoclonal antibody, NCC-ST-272].
Sekine T
Nihon Rinsho; 1990 Feb; 48 Suppl():1028-30. PubMed ID: 2192104
[No Abstract] [Full Text] [Related]
17. [Clinical significance of des-gamma-carboxy prothrombin assay as a tumor marker].
Yamano M
Nihon Rinsho; 1990 Feb; 48 Suppl():999-1002. PubMed ID: 1693989
[No Abstract] [Full Text] [Related]
18. Comparative studies of DU-PAN-2, carcinoembryonic antigen, and CA19-9 in the serum and bile of patients with pancreatic and biliary tract diseases: evaluation of the influence of obstructive jaundice.
Ohshio G; Manabe T; Watanabe Y; Endo K; Kudo H; Suzuki T; Tobe T
Am J Gastroenterol; 1990 Oct; 85(10):1370-6. PubMed ID: 2220731
[TBL] [Abstract][Full Text] [Related]
19. [Tumor markers for pancreatic and biliary tract cancer].
Takezako Y; Okusaka T; Ueno H; Ikeda M; Morizane C; Najima M
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1443-6. PubMed ID: 15446574
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of CA 19-9, TPA, IAP and 5'-NPD-V as tumor markers of hepatocellular, bile duct and pancreas carcinoma].
Takahashi H; Miyazaki H; Deura M; Shimizu Y; Asukata I; Kameda H
Gan No Rinsho; 1985 May; 31(6 Suppl):623-30. PubMed ID: 2411964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
